Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 9, 2013 - Issue 6
Submit an article Journal homepage
70
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Rescue therapy: ciclosporin or infliximab?

Fernando Rizzello Inflammatory Bowel Disease unit, Dipartimento di Scienze Mediche e Chirurgiche – DIMEC, Ospedale Sant’Orsola-Malpighi, University of Bologna, via Massarenti 9, Bologna 40138, Italy. [email protected]
,
Chiara Praticò Inflammatory Bowel Disease unit, Dipartimento di Scienze Mediche e Chirurgiche – DIMEC, Ospedale Sant’Orsola-Malpighi, University of Bologna, via Massarenti 9, Bologna 40138, Italy
,
Carlo Calabrese Inflammatory Bowel Disease unit, Dipartimento di Scienze Mediche e Chirurgiche – DIMEC, Ospedale Sant’Orsola-Malpighi, University of Bologna, via Massarenti 9, Bologna 40138, Italy
&
Paolo Gionchetti Inflammatory Bowel Disease unit, Dipartimento di Scienze Mediche e Chirurgiche – DIMEC, Ospedale Sant’Orsola-Malpighi, University of Bologna, via Massarenti 9, Bologna 40138, Italy
Pages 503-505 | Published online: 10 Jan 2014

References

  • Truelove SC, Witts LJ. Cortisone in ulcerative colitis: preliminary report on a therapeutic trial. BMJ 2(4884), 375–378 (1954).
  • Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1(7866), 1067–1070 (1974).
  • Travis SP, Farrant JM, Ricketts C et al. Predicting outcome in severe ulcerative colitis. Gut 38(6), 905–910 (1996).
  • Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin. Gastroenterol. Hepatol. 5(1), 103–110 (2007).
  • Lichtiger S, Present DH, Kornbluth A et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N. Engl. J. Med. 330(26), 1841–1845 (1994).
  • D’Haens G, Lemmens L, Geboes K et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 120(6), 1323–1329 (2001).
  • Van Assche G, D’Haens G, Noman M et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 125(4), 1025–1031 (2003).
  • Arts J, D’Haens G, Zeegers M et al. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm. Bowel Dis. 10(2), 73–78 (2004).
  • Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am. J. Gastroenterol. 94(6), 1587–1592 (1999).
  • Järnerot G, Hertervig E, Friis-Liby I et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128(7), 1805–1811 (2005).
  • Sandborn WJ, Rutgeerts P, Feagan BG et al. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology 137(4), 1250–1260; quiz 1520 (2009).
  • Rutgeerts P, Sandborn WJ, Feagan BG et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 353(23), 2462–2476 (2005).
  • Gustavsson A, Järnerot G, Hertervig E et al. Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3-year follow-up of the Swedish–Danish controlled infliximab study. Aliment. Pharmacol. Ther. 32(8), 984–989 (2010).
  • Chang KH, Burke JP, Coffey JC. Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis. Int. J. Colorectal Dis. 28(3), 287–293 (2013).
  • Laharie D, Bourreille A, Branche J et al.; Groupe d’Etudes Thérapeutiques des Affections Inflammatoires Digestives. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 380(9857), 1909–1915 (2012).
  • Kohn A, Daperno M, Armuzzi A et al. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment. Pharmacol. Ther. 26(5), 747–756 (2007).
  • Dignass A, Lindsay JO, Sturm A et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J. Crohns. Colitis 6(10), 991–1030 (2012).
  • Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121(2), 255–260 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.